Chronic Airways Assessment Test (CAAT)
Chronic Airways Assessment Test: A unified tool for assessing chronic airway diseases
CAAT can now be used for assessing respiratory health status in people with asthma, not just COPD
A simple and standardized health status measure
A standardized, easy to administer, health status measure for use across obstructive lung diseases.
Structure and components of the CAAT
8-items assessing aspects of disease relevant to patients.
Development and validation
The COPD assessment test (CAT) and the Chronic Airways Test (CAAT) were developed by an interdisciplinary group of international experts with support from GSK.
CAT and CAAT activities are monitored by a supervisory council that includes independent experts, one of which is chair of the council.
CAT, COPD Assessment Test, CAAT, Chronic Airways Assessment Test and the CAT logo are trademarks of the GSK group of companies.
Implementation and resources
Scan the QR code for the CAAT User Guide.
Documents for download
Read more details at
Fecha de publicación
September 2025
Categorías asociadas al artículo
Noticias relacionadas
Jornada RespirAP 2026: conexión entre Atención Primaria y Neumología para mejorar la atención al paciente respiratorio
Jornada RespirAP 2026 con las principales novedades en enfermedades respiratorias, Atención Primaria y Neumología presentadas por expertos nacionales.
The EXACERBANTES Study (Exacerbation of Chronic Obstructive Pulmonary Disease According to the ANTES Proposal): Rationale, Goals and Design
The EXACERBANTES Study explores treatable traits in COPD exacerbations, aiming to improve risk assessment and support personalized clinical management.
Joint statement from GOLD/GLI regarding the use of spirometry to define airflow obstruction and diagnose COPD
GOLD and GLI provide a joint position on spirometry for diagnosing COPD, supporting the fixed FEV1/FVC ratio in the appropriate clinical context.
A Brief History of COPD: As Told by Some of Its Senior Scientists and Clinicians
Explore the history of COPD and the evolution of disease concepts, treatment strategies, patient outcomes, pulmonary rehabilitation and clinical management.
Climate change and respiratory health: implications for respiratory clinicians in primary and specialist care
How climate change affects asthma and COPD, the role of air pollution and inhalers, and why sustainable respiratory care matters for patients and clinicians.
Indoor radon exposure and COPD in never smokers: a case–control study in a radon-prone area in Spain
Study on indoor radon exposure and its association with COPD risk and severity in never smokers in a radon-prone region.
Imagen obtenida de la presentación